Clinical Trial Update: Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome [NA]

View source ↗

Summary

This clinical trial conducted at Samsung Medical Center evaluated hyaluronidase as a trigger point injection for myofascial pain syndrome and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome

Drugs mentioned

• Hyaluronidase (hyaluronidase)

Snippet

Sponsor: Samsung Medical Center | Conditions: Myofascial Pain Syndrome | NA | Status: COMPLETED